Month: January 2018

The year 2017 has been challenging for Mallinckrodt plc MNK . The stock has tumbled 55.7% in the last twelve months compared with the industry’s decline of 25%. Armed with a worldwide presence, this specialty biopharmaceutical develops, manufactures, markets and distributes branded and generic specialty pharmaceutical and biopharmaceutical products and therapies along with nuclear medicine products. […]

Healthcare real estate investment trust (REIT) Welltower HCN is making pronounced efforts to strengthen its portfolio of healthcare assets. Most recently, the company announced entering into a definitive agreement for the acquisition of a portfolio of four rental continuing care retirement communities (CCRCs). […]

Apache Corporation APA , with a large geographically diversified reserve base, has been bearing the brunt of contracting production volumes and weak cash flows. Shares of Apache have declined 33.8% in a year compared with the industry ’s decline of 15.6% and the S&P 500 index’s rally of 18.2%. The company has also reported an average negative earnings surprise of 23.33% in the trailing four quarters […]

Waters Corporation WAT has managed to impress investors with its recent earnings streak, as the company’s earnings have trumped estimates in the four trailing quarters. We believe steady demand from pharmaceutical business, solid recurring revenues, strength in Asia as well as modest recovery in industrial markets will continue to be growth drivers, going forward. Driven by impressive growth drivers, the company’s stock has had an impressive run on the bourse in the past three months […]

Royal Dutch Shell plc RDS.A has decided not to proceed with the $80 million deal to offload its refinery operations in Denmark. The company had signed the divestment deal with Dansk Olieselskab AS in September 2016, which included the sale of Shell’s Fredericia refinery and local trading and supply activities. The deal was set for closure by the end of 2017, subject to satisfactory conditions […]

In this blog, we highlight two large-cap biotech stocks — Vertex Pharmaceuticals, Inc. VRTX and Alexion Pharmaceuticals, Inc. ALXN — that attracted investor attention last year and will likely remain in focus in the New Year as well […]

Shares of FedEx Corporation FDX have gained 34%, outperforming the industry ’s rally of 14.2% in 2017. In fact, the company has also outperformed its rival United Parcel Service UPS that gained only 3.9% in the same period. Reasons for FedEx’s Outperformance The strong e-commerce growth bodes well for FedEx […]

Enstar Group Limited ESGR recently completed the transaction of divesting its subsidiary, Pavonia Holdings (US), Inc. to a unit of Global Bankers Insurance Group, the insurance and reinsurance group of companies of Eli Global, LLC. Earlier announced on Feb 17, 2017, this transaction was completed for an aggregate amount of $120 million. […]

Anika Therapeutics Inc . ANIK recently obtained 510(k) approval from the U.S. Food and Drug Administration (FDA) for its latest hyaluronic acid (HA) technology-based Bone Repair treatment. […]

Novo Nordisk NVO is a global healthcare company and a leader in the worldwide diabetes market. Also, the company is a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity. However, let’s find out if Novo Nordisk will be a good investment in 2018. […]

Shares of Norfolk Southern Corporation NSC hit a 52-week high of $146.97 during the trading session on Jan 2, before retracing a bit to close the same at $146.96. Notably, the company’s shares performed well in 2017. […]

Principal Financial Group Inc . PFG remains well-poised for growth, banking on strong segmental performance, growing assets under management (AUM) and a solid capital position. […]

BP plc BP is expected to gain from the recently enacted changes to U.S. corporate taxes. BP expects future after-tax earnings to be favorably impacted owing to the cutback of the federal corporate income tax rate to 21% from 35% […]

Emergent BioSolutions, Inc. EBS offers specialized products to health care providers and governments to fulfill the unmet medical needs as well as combat emerging public health threats. BioThrax is the company's key Biodefense product and is the sole vaccine to be marketed for general use in case of both pre-exposure prophylaxis and post-exposure prophylaxis of anthrax disease […]

In its weekly release, Houston-based oilfield services player Baker Hughes, a GE company BHGE , reported a decrease in total rig counts in the United States. About the Rig Count Baker Hughes’ data, issued since 1944 at the end of every week, helps energy service providers gauge the overall business environment of the oil and gas industry. Change in Baker Hughes’ rotary rig count hampers demand for energy services like drilling, completion and production provided by the likes of Halliburton Company HAL , Schlumberger Ltd. […]

Valeant Pharmaceuticals International, Inc . VRX announced that the parties in the cases of Basile v. Valeant Pharmaceuticals International, Inc […]